Contact US | Chinese
You Position: Home > Journal issue
Drug Evaluation Drug Evaluation

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

Drug Evaluation

Items 1-5 of 12
«Preious | of 3 |
1

The Safety end Tolerability of Glucagon-like Peptide 1 Analogues in the Treatment of Type 2 Diabetes

DRUG EVALUATION, Volume 08, Issue 2,2011, Pages 28-32, doi:10.3969/j.issn.1672-2809.2011.02.007

2

Introduction of European Countries Remuneration Systems for Pharmacists

DRUG EVALUATION, Volume 08, Issue 2,2011, Pages 8-11, doi:10.3969/j.issn.1672-2809.2011.02.002

3

Medication Reconciliation and Clinical Practice

DRUG EVALUATION, Volume 08, Issue 2,2011, Pages 14-17,26, doi:10.3969/j.issn.1672-2809.2011.02.004

4

Pharmaceutical Service Fee's Role on Promoting the Development of PIVAS

DRUG EVALUATION, Volume 08, Issue 2,2011, Pages 12-13, doi:10.3969/j.issn.1672-2809.2011.02.003

5

Pharmaceutical Care on Hyperthyroidism during Pregnancy

DRUG EVALUATION, Volume 08, Issue 2,2011, Pages 41-43, doi:10.3969/j.issn.1672-2809.2011.02.010

Items 1-5 of 12
«Preious | of 3 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn